Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 From IFN to TNF: a journey into realms of lore.

Literature DB >> 19448652

From IFN to TNF: a journey into realms of lore.

Jan Vilcek¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2009 PMID： 19448652 DOI： 10.1038/ni0609-555

Source DB: PubMed Journal: Nat Immunol ISSN： 1529-2908 Impact factor: 25.606

× No keyword cloud information.

23 in total

Review 1. Interferon research BC (before cloning).

Authors: J Vilcek
Journal: Curr Top Microbiol Immunol Date: 2007 Impact factor: 4.291

2. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts.

Authors: T H Lee; G W Lee; E B Ziff; J Vilcek
Journal: Mol Cell Biol Date: 1990-05 Impact factor: 4.272

3. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors: B Beutler; I W Milsark; A C Cerami
Journal: Science Date: 1985-08-30 Impact factor: 47.728

4. Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts.

Authors: L F Reis; T Ho Lee; J Vilcek
Journal: J Biol Chem Date: 1989-10-05 Impact factor: 5.157

5. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.

Authors: G E Nedwin; S L Naylor; A Y Sakaguchi; D Smith; J Jarrett-Nedwin; D Pennica; D V Goeddel; P W Gray
Journal: Nucleic Acids Res Date: 1985-09-11 Impact factor: 16.971

6. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

Authors: M Tsujimoto; Y K Yip; J Vilcek
Journal: Proc Natl Acad Sci U S A Date: 1985-11 Impact factor: 11.205

7. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.

Authors: B Beutler; D Greenwald; J D Hulmes; M Chang; Y C Pan; J Mathison; R Ulevitch; A Cerami
Journal: Nature Date: 1985 Aug 8-14 Impact factor: 49.962

8. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor.

Authors: H G Wisniewski; W H Burgess; J D Oppenheim; J Vilcek
Journal: Biochemistry Date: 1994-06-14 Impact factor: 3.162

9. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.

Authors: S A Siegel; D J Shealy; M T Nakada; J Le; D S Woulfe; L Probert; G Kollias; J Ghrayeb; J Vilcek; P E Daddona
Journal: Cytokine Date: 1995-01 Impact factor: 3.861

10. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Authors: J Vilcek; V J Palombella; D Henriksen-DeStefano; C Swenson; R Feinman; M Hirai; M Tsujimoto
Journal: J Exp Med Date: 1986-03-01 Impact factor: 14.307

7 in total

From IFN to TNF: a journey into realms of lore.

Review 1. Interferon research BC (before cloning).

2. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts.

3. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

4. Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts.

5. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization.

6. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

7. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.

8. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor.

9. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.

10. Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.

Review 1. The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin.

2. HOIP limits anti-tumor immunity by protecting against combined TNF and IFN-gamma-induced apoptosis.

3. Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

4. The high costs of "free" drug samples.

Review 5. A fascinating story of the discovery & development of biologicals for use in clinical medicine.

Review 6. Decoding inflammation, its causes, genomic responses, and emerging countermeasures.

7. Beyond Serendipity to an Algorithmic Approach.